Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, et al.

Circulation. 1994 Mar;89(3):975-90.

PMID:
8124838
2.
3.

Intensive lifestyle changes for reversal of coronary heart disease.

Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ.

JAMA. 1998 Dec 16;280(23):2001-7. Erratum in: JAMA 1999 Apr 21;281(15):1380.

PMID:
9863851
4.

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.

Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, de Faire U.

Lancet. 1996 Mar 30;347(9005):849-53.

PMID:
8622389
5.
6.

Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).

Kleemann A, Eckert S, von Eckardstein A, Lepper W, Schernikau U, Gleichmann U, Hanrath P, Fleck E, Neiss A, Kerber S, Assmann G, Breithardt G; CLAPT Study..

Eur Heart J. 1999 Oct;20(19):1393-406.

7.

Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.

de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.

Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:257-63. Review.

PMID:
9211018
9.
10.

The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.

Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L, et al.

Online J Curr Clin Trials. 1992 Oct 23;Doc No 26:[9897 words; 83 paragraphs]. Erratum in: Online J Curr Clin Trials 1992 Nov 14;Doc No 29:[85 words; 2.

PMID:
1343613
11.
12.

Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).

de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.

Eur Heart J. 1996 Dec;17 Suppl F:37-42. Review.

13.

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT.

N Engl J Med. 1990 Nov 8;323(19):1289-98.

14.

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.

Whitney EJ, Krasuski RA, Personius BE, Michalek JE, Maranian AM, Kolasa MW, Monick E, Brown BG, Gotto AM Jr.

Ann Intern Med. 2005 Jan 18;142(2):95-104.

PMID:
15657157
15.

Lifestyle modification program in management of patients with coronary artery disease: the clinical experience in a tertiary care hospital.

Rutledge JC, Hyson DA, Garduno D, Cort DA, Paumer L, Kappagoda CT.

J Cardiopulm Rehabil. 1999 Jul-Aug;19(4):226-34.

PMID:
10453429
16.

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study.

[No authors listed]

Lancet. 2001 Mar 24;357(9260):905-10. Erratum in: Lancet 2001 Jun 9;357(9271):1890.

PMID:
11289345
18.

Internet-based interventions for the secondary prevention of coronary heart disease.

Devi R, Singh SJ, Powell J, Fulton EA, Igbinedion E, Rees K.

Cochrane Database Syst Rev. 2015 Dec 22;(12):CD009386. doi: 10.1002/14651858.CD009386.pub2. Review.

PMID:
26691216
19.

Regression of severe atherosclerotic plaque in patients with mild elevation of LDL cholesterol.

Schaefer S, Hussein H, Gershony GR, Rutledge JC, Kappagoda CT.

J Investig Med. 1997 Dec;45(9):536-41.

PMID:
9444880
20.

New methodologies for studying the prevention of atherosclerosis.

Haskell WL, Fair J, Sanders W, Alderman EL.

Ann Clin Res. 1988;20(1-2):39-45.

PMID:
3408211
Items per page

Supplemental Content

Support Center